PDT Partners LLC Has $1.03 Million Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

PDT Partners LLC trimmed its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 55.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,502 shares of the company’s stock after selling 19,051 shares during the quarter. PDT Partners LLC’s holdings in Ryan Specialty were worth $1,029,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in RYAN. Fred Alger Management LLC boosted its stake in Ryan Specialty by 8.9% during the third quarter. Fred Alger Management LLC now owns 57,727 shares of the company’s stock worth $3,832,000 after acquiring an additional 4,709 shares in the last quarter. Verition Fund Management LLC raised its holdings in shares of Ryan Specialty by 40.5% during the third quarter. Verition Fund Management LLC now owns 11,774 shares of the company’s stock valued at $782,000 after purchasing an additional 3,396 shares during the period. Captrust Financial Advisors boosted its position in shares of Ryan Specialty by 9.3% during the 3rd quarter. Captrust Financial Advisors now owns 9,405 shares of the company’s stock worth $624,000 after purchasing an additional 798 shares in the last quarter. Walleye Capital LLC grew its stake in shares of Ryan Specialty by 294.6% in the 3rd quarter. Walleye Capital LLC now owns 76,903 shares of the company’s stock valued at $5,106,000 after buying an additional 57,413 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Ryan Specialty by 0.4% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 262,166 shares of the company’s stock valued at $17,405,000 after buying an additional 935 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Insider Transactions at Ryan Specialty

In related news, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. This trade represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

RYAN has been the topic of several recent research reports. Barclays increased their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. UBS Group lifted their price target on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research report on Tuesday, August 13th. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. The Goldman Sachs Group raised their price objective on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. Finally, Bank of America upped their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $71.67.

Ryan Specialty Stock Up 0.4 %

Ryan Specialty stock opened at $75.40 on Monday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The stock has a market cap of $19.74 billion, a PE ratio of 97.92, a price-to-earnings-growth ratio of 1.71 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a fifty-two week low of $41.49 and a fifty-two week high of $75.97. The firm’s 50-day simple moving average is $70.23 and its 200 day simple moving average is $63.34.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.41. The company had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty’s quarterly revenue was up 20.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.32 earnings per share. Research analysts predict that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were given a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 0.58%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is presently 57.14%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.